Pirfenidone
Back to searchMolecule Structure
Scientific Name
Pirfenidone
Description of the Drug
Pirfenidone is an agent used for the treatment of idiopathic pulmonary fibrosis (IPF).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04951
http://www.drugbank.ca/drugs/DB04951
Brand Name(s)
Esbriet
Company Owner(s)
Micro Labs Ltd, Teva Pharmaceuticals Usa Inc, Msn Laboratories Private Ltd, Alembic Pharmaceuticals Ltd, Sandoz Inc, Laurus Labs Ltd, Accord Healthcare Inc, Aizant Drug Research Solutions Private Ltd, Amneal Eu Ltd, Genentech Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4708 | |
Human Metabolome Database | HMDB0256594 | |
DrugBank | DB04951 | |
PubChem: Thomson Pharma | 14772813 | |
PubChem | 40632 | |
LINCS | LSM-4190 | |
Nikkaji | J10.084F | |
BindingDB | 50005201 | |
EPA CompTox Dashboard | DTXSID4045183 | |
DrugCentral | 4224 | |
ChemicalBook | CB5299210 | CB52511343 |
Guide to Pharmacology | 7532 | |
rxnorm | PIRFENIDONE | ESBRIET |
PubChem: Drugs of the Future | 12012763 | |
ChEBI | 32016 | |
ZINC | ZINC000000001958 |